3 Biotech Stocks for Earnings Beats this SeasonEven a quarter back, tax inversion deals were quite a rage among most of the U.S. based biotech firms. However, these tax dodging strategies have fallen apart ever since the U.S. Department of Treasury issued a notice related to tax inversion deals. We have seen AbbVie Inc. ( ABBV ) calling off its […]
The S&P 500 closed at a record high and fellow benchmarks also ended in the green boosted by deal news. Possibility of stimulus measures in the Eurozone also lifted the benchmarks. The S&P crossed the 2000-point milestone for the first time, but failed to end above that mark. However, full day trading volume was the lowest this year.For a look […]
At any time, most biotech stocks can go on significant price runs, especially when news events are involved.For example, InterMune (NASDAQ: ITMN) has jumped about 35 percent today on the news that Roche has agreed to buy the company for $8.3 billion.Now, that’s a one-day pop, but which biotech stock has had the best performance over the last week?Well, the […]
Benchmarks ended in the green as gains in biotech stocks offset discouraging retail sales numbers. Disappointing retail sales also negated concerns about a sooner-than-expected interest rate hike. Healthcare and technology stocks helped the S&P to hit a two-week high. However, disappointing earnings from Macy’s eroded some of yesterday’s gains.For a look at the issues currently facing the markets, make sure […]
The Fed says the economy remains healthy enough that it will continue to taper back its QE stimulus at a rate of $10 billion a month, with plans to have it at zero by October.Speculation now is on when it will begin the next step toward returning its monetary policy to normal, by beginning to raise interest rates from their […]
The first quarter of the year brought with it some major selling in the momentum names, specifically in biotech stocks.
Since then, the overall stock market has recovered, and so have most biotech stocks with it. Unfortunately, while the market has hit new highs, most biotechs have not.
Some biotech stocks, however, have performed better than others, and some have actually outperformed […]
